Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Liver Diseases

Free Subscription 13.06.2022 1 AJR Am J Roentgenol 3 Am J Gastroenterol 1 Biochem Biophys Res Commun 3 BMC Cancer 7 BMC Gastroenterol 7 Dig Dis Sci 1 Eur Radiol 3 Gut 2 Hepatology 1 Int J Cancer 2 J Hepatol 4 PLoS One 1 Semin Liver Dis 3 Transplant Proc

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. DILLMAN JR, Thapaliya S, Tkach JA, Trout AT, et al
   Quantification of Hepatic Steatosis by Ultrasound: Prospective Comparison to MRI Proton-Density Fat Fraction as Reference Standard.
   AJR Am J Roentgenol. 2022 Jun 8. doi: 10.2214/AJR.22.27878.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

2. KANN AE, Jepsen P, Madsen LG, Crooks C, et al
   Motivation to Reduce Drinking and Engagement in Alcohol Misuse Treatment in Alcohol-Related Liver Disease: A National Health Survey.
   Am J Gastroenterol. 2022;117:918-922.
   PubMed         Abstract available
   
   
3. SCORLETTI E, Creasy KT, Vujkovic M, Vell M, et al
   Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease.
   Am J Gastroenterol. 2022;117:927-930.
   PubMed         Abstract available
   
   
4. BAJAJ JS, Wong F, Kamath PS, Lai JC, et al
   Acute-on-Chronic Liver Failure.
   Am J Gastroenterol. 2022;117:831-834.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

5. ZHANG X, Tao X, Feng F
   Downregulation of C12orf75 gene inhibits migration and invasion of liver cancer cell via suppressing the Wnt/beta-catenin signaling pathway in vitro.
   Biochem Biophys Res Commun. 2022;614:92-99.
   PubMed         Abstract available
   
   

   
   BMC Cancer

6. YELLAPU NK, Ly T, Sardiu ME, Pei D, et al
   Synergistic anti-proliferative activity of JQ1 and GSK2801 in triple-negative breast cancer.
   BMC Cancer. 2022;22:627.
   PubMed         Abstract available
   
   
7. ZENG C, Zhang L, Luo C, Yang C, et al
   A stratification model of hepatocellular carcinoma based on expression profiles of cells in the tumor microenvironment.
   BMC Cancer. 2022;22:613.
   PubMed         Abstract available
   
   
8. XU X, Ding P, Shi L, Wu G, et al
   LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression.
   BMC Cancer. 2022;22:630.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

9. KUROKAWA S, Yoneda M, Ogawa Y, Honda Y, et al
   Two differentially methylated region networks in nonalcoholic fatty liver disease, viral hepatitis, and hepatocellular carcinoma.
   BMC Gastroenterol. 2022;22:278.
   PubMed         Abstract available
   
   
10. FARHADNEJAD H, Tehrani AN, Jahromi MK, Teymoori F, et al
    The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults.
    BMC Gastroenterol. 2022;22:267.
    PubMed         Abstract available
    
    
11. NARUTO K, Kawaoka T, Kodama K, Ogawa Y, et al
    Efficacy and safety of chemoradiation therapy using one-shot cisplatin via hepatic arterial infusion for advanced hepatocellular carcinoma with major macrovascular invasion: a single-arm retrospective cohort study.
    BMC Gastroenterol. 2022;22:275.
    PubMed         Abstract available
    
    
12. XIE J, Zheng C, Xie J, Wang F, et al
    No significant relationship exists between tumor size and prognosis in distant metastatic hepatocellular carcinoma: a propensity score matching analysis based on SEER database.
    BMC Gastroenterol. 2022;22:274.
    PubMed         Abstract available
    
    
13. ABONGWA LE, Nyamache AK, Charles F, Torimiro J, et al
    Risk factors of severe hepatotoxicity among HIV-1 infected individuals initiated on highly active antiretroviral therapy in the Northwest Region of Cameroon.
    BMC Gastroenterol. 2022;22:286.
    PubMed         Abstract available
    
    
14. LI X, Gong M, Fu S, Zhang J, et al
    Establishment of MELD-lactate clearance scoring system in predicting death risk of critically ill cirrhotic patients.
    BMC Gastroenterol. 2022;22:280.
    PubMed         Abstract available
    
    
15. ZHANG X, Huang WJ, Zhang ML, Wang W, et al
    Utility of mean platelet volume in differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    BMC Gastroenterol. 2022;22:288.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

16. KUGELMAS M, Zapata I, Tawil J, Pessetto A, et al
    Liver Cirrhosis Increases the Risk of Developing Advanced Colon Polyps.
    Dig Dis Sci. 2022 Jun 7. pii: 10.1007/s10620-022-07561.
    PubMed         Abstract available
    
    
17. SIDDIQUI MA, Suresh S, Simmer S, Abu-Ghanimeh M, et al
    Increased Morbidity and Mortality in COVID-19 Patients with Liver Injury.
    Dig Dis Sci. 2022;67:2577-2583.
    PubMed         Abstract available
    
    
18. ARTEEL GE, Singhvi A, Feldman R, Althouse AD, et al
    Coexistent Alcohol-Related Liver Disease and Alcohol-Related Pancreatitis: Analysis of a Large Heath Care System Cohort.
    Dig Dis Sci. 2021 May 7. pii: 10.1007/s10620-021-07010.
    PubMed         Abstract available
    
    
19. NABI O, Boursier J, Lacombe K, Mathurin P, et al
    Comorbidities Are Associated with Fibrosis in NAFLD Subjects: A Nationwide Study (NASH-CO Study).
    Dig Dis Sci. 2022;67:2584-2593.
    PubMed         Abstract available
    
    
20. GLASS L, Asefa H, Volk M, Lok AS, et al
    Disease Knowledge, Health-Related Quality of Life, and Lifestyle Behavior Change in Patients with Nonalcoholic Fatty Liver Disease: Impact of an Educational Intervention.
    Dig Dis Sci. 2022;67:2123-2133.
    PubMed         Abstract available
    
    
21. TESTINO G, Vignoli T, Patussi V, Allosio P, et al
    Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA).
    Dig Dis Sci. 2022;67:1975-1986.
    PubMed         Abstract available
    
    
22. PAN AY, Zilberstein NF, Farnan JM, McConville JF, et al
    Recently Graduated Medical Students Lack Exposure to and Comfort with Chronic Liver Diseases.
    Dig Dis Sci. 2022;67:2081-2085.
    PubMed         Abstract available
    
    

    
    Eur Radiol

23. PENG Y, Shen H, Tang H, Huang Y, et al
    Nomogram based on CT-derived extracellular volume for the prediction of post-hepatectomy liver failure in patients with resectable hepatocellular carcinoma.
    Eur Radiol. 2022 Jun 9. pii: 10.1007/s00330-022-08917.
    PubMed         Abstract available
    
    

    
    Gut

24. GRACIA-SANCHO J, Dufour JF
    NTCP: a pharmacological target for multiple liver conditions.
    Gut. 2022;71:1248-1250.
    PubMed        
    
    
25. PAVLIDES M, Mozes FE, Harrison SA
    Reply to: Non-invasive tests and advanced chronic liver disease in NAFLD: two steps forward and one step back?
    Gut. 2022;71:1453-1454.
    PubMed        
    
    
26. SALHAB A, Amer J, Lu Y, Safadi R, et al
    Sodium(+)/taurocholate cotransporting polypeptide as target therapy for liver fibrosis.
    Gut. 2022;71:1373-1385.
    PubMed         Abstract available
    
    

    
    Hepatology

27. DELTENRE P, Zanetto A, Saltini D, Moreno C, et al
    The role of TIPS in patients with cirrhosis and ascites: recent evolution and open questions.
    Hepatology. 2022 Jun 4. doi: 10.1002/hep.32596.
    PubMed         Abstract available
    
    
28. HOLMAN A, Parikh N, Clauw DJ, Williams DA, et al
    Rethinking the management of pain in cirrhosis: toward precision therapy for pain.
    Hepatology. 2022 Jun 5. doi: 10.1002/hep.32598.
    PubMed         Abstract available
    
    

    
    Int J Cancer

29. ZHENG G, Bouamar H, Cserhati M, Zeballos CR, et al
    Integrin alpha 6 (ITGA6) is upregulated and drives hepatocellular carcinoma progression through integrin alpha6beta4 complex.
    Int J Cancer. 2022 Jun 3. doi: 10.1002/ijc.34146.
    PubMed         Abstract available
    
    

    
    J Hepatol

30. GRAVELY AK, Vibert E, Sapisochin G
    Surgical treatment of intrahepatic cholangiocarcinoma.
    J Hepatol. 2022 Jun 5. pii: S0168-8278(22)00017.
    PubMed        
    
    
31. VILLANUEVA C, Torres F, Sarin SK, Shah HA, et al
    Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis.
    J Hepatol. 2022 May 31. pii: S0168-8278(22)00336.
    PubMed         Abstract available
    
    

    
    PLoS One

32. RIDJAB DA, Ivan I, Budiman F, Tenggara R, et al
    Evaluation of subclinical ventricular systolic dysfunction assessed using global longitudinal strain in liver cirrhosis: A systematic review, meta-analysis, and meta-regression.
    PLoS One. 2022;17:e0269691.
    PubMed         Abstract available
    
    
33. EFREMOV Y, Ermolaeva A, Vladimirov G, Gordleeva S, et al
    A mathematical model of in vitro hepatocellular cholesterol and lipoprotein metabolism for hyperlipidemia therapy.
    PLoS One. 2022;17:e0264903.
    PubMed         Abstract available
    
    
34. LYNCH EC, Liu Z, Liu L, Wang X, et al
    Disrupting Osr1 expression promoted hepatic steatosis and inflammation induced by high-fat diet in the mouse model.
    PLoS One. 2022;17:e0268344.
    PubMed         Abstract available
    
    
35. PARK J, Kwon HJ, Sohn W, Cho JY, et al
    Risk of liver fibrosis in patients with prediabetes and diabetes mellitus.
    PLoS One. 2022;17:e0269070.
    PubMed         Abstract available
    
    

    
    Semin Liver Dis

36. KULKARNI AV, Premkumar M, Arab JP, Kumar K, et al
    EARLY DIAGNOSIS AND PREVENTION OF INFECTIONS IN CIRRHOSIS.
    Semin Liver Dis. 2022 Jun 7. doi: 10.1055/a-1869-7607.
    PubMed         Abstract available
    
    

    
    Transplant Proc

37. CUNHA MR, Waisberg DR, Ernani L, Fernandes MR, et al
    Duodenal Necrosis and Nonvariceal Digestive Bleeding After Terlipressin Administration for Treatment of Hepatorenal Syndrome: a Case Report of a Novel Side Effect of a Commonly Used Drug.
    Transplant Proc. 2022 Jun 5. pii: S0041-1345(22)00306.
    PubMed         Abstract available
    
    
38. MIKOLAJCZYK-KORNIAK N, Baczkowska T, Tronina O, Durlik M, et al
    Noninvasive Diagnostic Methods for the Assessment of Hepatic Fibrosis in Liver Transplant Recipients.
    Transplant Proc. 2022 Jun 2. pii: S0041-1345(22)00185.
    PubMed         Abstract available
    
    
39. MARIA SILVA A, Reis Waisberg D, Ribeiro Fernandes M, Martino RB, et al
    Hepatic Venous Outflow Obstruction in Adult Deceased Donor Liver Transplantation: Classic Piggyback Implantation Versus a Modified Technique that Widens the Ostium of the Recipient's Left and Middle Hepatic Veins.
    Transplant Proc. 2022 Jun 2. pii: S0041-1345(22)00310.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: